Consumer goods account for the largest proportion of items searched and purchased on the Internet. Unsurprisingly, it is the sector most awash with counterfeit goods. With so many counterfeit goods available, it is often impossible for the public to distinguish fakes from the real thing.
In the case of pharmaceutical drugs, this is not only an IP rights issue but one of safety and efficacy, as counterfeit drugs are invariably made from lower-quality ingredients and do not face the same rigorous inspection processes as their genuine counterparts.
Companies invest a great deal of time and money to procure and license intellectual property rights that protect their goods. SIPI is here to monitor, investigate, and when required, implement enforcement procedures to protect those investments.